Abstract | OBJECTIVE: MATERIALS AND METHODS: Eight adult patients with chronic shoulder pain, as defined above, who either did not respond to surgical intervention or who were deemed not ideal surgical candidates underwent permanent axillary PNS therapy. Follow-up ranged from 44 to 733 days (avg 445 days). The primary outcome was percent pain reduction, determined by the change in average numerical pain rating scale (NPRS). Additionally, secondary outcome measures were the change in opioid requirements and satisfaction rate. RESULTS: Based on the ≥50% pain reduction for treatment success, 88% (7/8) were "responders." Overall average pain reduction was 67% and 70% among responders; 62.5% (5/8) of patients reported that they used opioids prior to axillary PNS therapy for pain relief. Among these patients, 100% reported decreased opioid use after axillary PNS implant, with an average reduction of 88% (based on self-reported reductions). Additionally, 100% (8/8) of patients reported that they would recommend this therapy to other patients suffering from chronic pain. CONCLUSIONS: This retrospective case series provides level IV evidence supporting the use of axillary PNS therapy for the management of chronic shoulder pain. Additional, higher-level studies are required to further support its use.
|
Authors | John Taylor Mansfield, Mehul J Desai |
Journal | Neuromodulation : journal of the International Neuromodulation Society
(Neuromodulation)
Vol. 23
Issue 6
Pg. 812-818
(Aug 2020)
ISSN: 1525-1403 [Electronic] United States |
PMID | 31930660
(Publication Type: Case Reports)
|
Copyright | © 2020 International Neuromodulation Society. |
Topics |
- Adult
- Humans
- Peripheral Nerves
- Retrospective Studies
- Shoulder Joint
- Shoulder Pain
(therapy)
- Transcutaneous Electric Nerve Stimulation
- Treatment Outcome
|